Date Title Description PDF
25 Apr 2023 On business and financial situation ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) Download
21 Feb 2023 On business and financial situation The Company releases the full year 2022 financial results presentation. Download
21 Feb 2023 On business and financial situation The Company releases the press release related to the full year 2022 financial results. Download
21 Feb 2023 On business and financial situation The company releases the Integrated Report for the year 2022 Download
21 Feb 2023 About Corporate Governance The Company informs about the agreements adopted by the Board of Directors Download

Pages

Date Title Description PDF
21 Oct 2021 Liquidity and counterparty agreements Download
21 Oct 2021 On business and financial situation The Company informs of the delay in the decision on Risperidone ISM® by the U.S. Food and Drug Administration (“FDA”). Download
07 Oct 2021 Liquidity and counterparty agreements Download
04 Oct 2021 Liquidity and counterparty agreements Download
01 Sep 2021 On business and financial situation ROVI informs about the joint statement from Moderna and Takeda on the investigation of suspended lots of the vaccine Download

Pages

Date Title Description PDF
28 Jul 2016 Información sobre resultados (2) ROVI releases the press release related to the 2016 first half results Download
28 Jul 2016 Información sobre resultados ROVI releases the presentation related to the 2016 first half results Download
05 Jul 2016 Contratos de liquidez y contrapartida Liquidity contract: transactions conducted in the second quarter of 2016 Download
24 Jun 2016 Información sobre dividendos The Company informs about the dividends payment Download
31 May 2016 Convocatorias y acuerdos de Juntas y Asambleas generales ROVI releases the information related to the agreements adopted by the 2016 General Shareholders Meeting Download

Pages